Growth Metrics

Xtant Medical Holdings (XTNT) Liabilities and Shareholders Equity (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Liabilities and Shareholders Equity for 16 consecutive years, with $106.3 million as the latest value for Q3 2025.

  • Quarterly Liabilities and Shareholders Equity rose 7.52% to $106.3 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $399.5 million through Sep 2025, up 4.85% year-over-year, with the annual reading at $93.8 million for FY2024, 1.32% up from the prior year.
  • Liabilities and Shareholders Equity for Q3 2025 was $106.3 million at Xtant Medical Holdings, up from $103.5 million in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $106.3 million in Q3 2025, with the low at $52.7 million in Q2 2022.
  • Average Liabilities and Shareholders Equity over 5 years is $76.4 million, with a median of $65.2 million recorded in 2023.
  • The sharpest move saw Liabilities and Shareholders Equity dropped 11.67% in 2022, then soared 64.15% in 2023.
  • Over 5 years, Liabilities and Shareholders Equity stood at $54.7 million in 2021, then grew by 10.12% to $60.2 million in 2022, then soared by 53.77% to $92.6 million in 2023, then grew by 1.32% to $93.8 million in 2024, then rose by 13.3% to $106.3 million in 2025.
  • According to Business Quant data, Liabilities and Shareholders Equity over the past three periods came in at $106.3 million, $103.5 million, and $95.8 million for Q3 2025, Q2 2025, and Q1 2025 respectively.